Verified Nov 2026
Other
·

Hawthorne, New York
·
Since 1950
Taro Pharmaceuticals, headquartered in Hawthorne, New York and founded in 1950, is a multinational pharmaceutical manufacturer with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops prescription and over-the-counter medications across dermatology, cardiology, and neurology. Taro became privately held under Sun Pharma ownership following a merger in June 2024 and operates research centers in Haifa, Brampton, and New York, with vertical integration of active pharmaceutical ingredient synthesis.
Taro Pharmaceuticals at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1950
Headquarters
Hawthorne, New York
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Taro Pharmaceuticals, headquartered in Hawthorne, New York and founded in 1950, is a multinational pharmaceutical manufacturer with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops prescription and over-the-counter medications across dermatology, cardiology, and neurology. Taro became privately held under Sun Pharma ownership following a merger in June 2024 and operates research centers in Haifa, Brampton, and New York, with vertical integration of active pharmaceutical ingredient synthesis.
At a glance
Attribute | Detail |
|---|---|
Founded | 1950 |
Headquarters | Hawthorne, New York |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What Taro Pharmaceuticals makes
The company manufactures topical dermatological treatments, solid dosage forms for cardiology and neurology, generic medicines, and over-the-counter products, synthesizing many active pharmaceutical ingredients in-house.
Latest developments
2026-10-09 — Taro Pharma Says MDL Deal Bars States' Duplicative Claims - Law360 Healthcare Authority (law360.com)
2026-03-02 — Taro pharmaceutical industries | Radio Compass News | PharmaCompass.com (pharmacompass.com)
2025-10-23 — [Taro Pharmaceuticals Inc.
2025-03-19 — Sun Pharma completes acquisition of Antibe Therapeutics in CAD 4.5 million (pharmatutor.org)
Company details
Following its acquisition by Sun Pharma in June 2024, Taro serves healthcare professionals, patients, and pharmacies across the United States, Canada, Israel, and other global markets. Taro Pharmaceuticals was founded in 1950, has an estimated 1,000-5,000 employees, and is headquartered in Hawthorne, New York.
Frequently asked questions
What does Taro Pharmaceuticals do?
Taro Pharmaceuticals, headquartered in Hawthorne, New York and founded in 1950, is a multinational pharmaceutical manufacturer with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops prescription and over-the-counter medications across dermatology, cardiology, and neurology. Taro became privately held under Sun Pharma ownership following a merger in June 2024 and operates research centers in Haifa, Brampton, and New York, with vertical integration of active pharmaceutical ingredient synthesis.
Where is Taro Pharmaceuticals headquartered?
Taro Pharmaceuticals is headquartered in Hawthorne, New York (3 Skyline Drive, Hawthorne, New York, 10532).
When was Taro Pharmaceuticals founded?
Taro Pharmaceuticals was founded in 1950.
How big is Taro Pharmaceuticals?
Taro Pharmaceuticals has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
